Aft Pharmaceuticals
(ASX) AFP
Aft Pharmaceuticals Financials at a Glance
Market Cap
$298.87M
Revenue (TTM)
$433.83M
Net Income (TTM)
$29.03M
EPS (TTM)
$0.15
P/E Ratio
18.87
Dividend
$0.02
Beta (Volatility)
-0.13 (Low)
Dividend
$0.02
Beta (Volatility)
-0.13 (Low)
Price
$2.85
Volume
0
Open
$2.85
Price
$2.85
Volume
0
Open
$2.85
Previous Close
$2.85
Daily Range
$2.85 - $2.85
52-Week Range
$2.20 - $3.37
Dividend
$0.02
Beta (Volatility)
-0.13 (Low)
Price
$2.85
Volume
0
Open
$2.85
Previous Close
$2.85
Daily Range
$2.85 - $2.85
52-Week Range
$2.20 - $3.37
AFP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aft Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
119
CEO
Hartley Atkinson, PhD
Website
www.aftpharm.comHeadquarters
Auckland, 0622, NZ
AFP Financials
Key Financial Metrics (TTM)
Gross Margin
45%
Operating Margin
11%
Net Income Margin
7%
Return on Equity
19%
Return on Capital
25%
Return on Assets
10%
Earnings Yield
5.30%
Dividend Yield
0.01%
Payout Ratio
10.82%
Stock Overview
Market Cap
$298.87M
Shares Outstanding
104.87M
Volume
0
Short Interest
0.00%
Avg. Volume
1.15K
Financials (TTM)
Gross Profit
$89.19M
Operating Income
$11.70M
EBITDA
$21.52M
Operating Cash Flow
$13.18M
Capital Expenditure
$6.95M
Free Cash Flow
$6.22M
Cash & ST Invst.
$11.11M
Total Debt
$30.00M
Aft Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$114.02M
+36.4%
Gross Profit
$49.29M
+37.2%
Gross Margin
43.23%
N/A
Market Cap
$298.87M
N/A
Market Cap/Employee
$2.72M
N/A
Employees
110
N/A
Net Income
$3.27M
+80.1%
EBITDA
$7.13M
+91.0%
Quarterly Fundamentals
Net Cash
$25.47M
+25.2%
Accounts Receivable
$36.65M
+9.7%
Inventory
$57.38M
+5.0%
Long Term Debt
$2.85M
-92.2%
Short Term Debt
$34.72M
+868.4%
Return on Assets
10.17%
N/A
Return on Invested Capital
24.61%
N/A
Free Cash Flow
$672.53K
-109.1%
Operating Cash Flow
$609.04K
-108.2%